Respiratory Department, King's Mill Hospital, Sutton-in-Ashfield, UK.
Int J Risk Saf Med. 2022;33(S1):S73-S77. doi: 10.3233/JRS-227028.
The British Thoracic Society (BTS) Acute Non-Invasive Ventilation (NIV) standards state all patients who require acute NIV should be initiated on NIV within two hours of hospital admission. The delivery of acute NIV is a time critical intervention as prompt application of acute NIV substantially reduces mortality for patients with acute hypercapnic respiratory failure.
This audit aimed to assess the number of patients for whom there is a delay in the initiation of acute NIV. We also assessed the outcome of admission for patients started on acute NIV.
Data was collected on patients admitted to Kings Mill Hospital for acute NIV between 1/2/2019 and 31/3/2019. Awareness and knowledge of acute NIV was highlighted as an area for improvement. E-learning packages on 'Acute NIV' were designed and sent to medical-staff. The audit was repeated for patients admitted for acute NIV between 1/2/2020 and 31/3/2020 and analysed using chi-square tests.
25 patients were included in the initial audit and 30 patients in the re-audit. Prior to intervention 31% of patients had a delay in the initiation of acute NIV, which increased to 77% post-intervention (p < 0.0001). Prior to intervention there was a mortality rate of 17% and a mortality rate of 13% post-intervention (p > 0.05).
Further work is required to ensure the sustained delivery of acute NIV to BTS standards, however variable achievements in the targets does not seem to have a significant adverse effect on patient outcomes.
英国胸科学会(BTS)急性无创通气(NIV)标准规定,所有需要急性 NIV 的患者应在入院后两小时内开始接受 NIV。急性 NIV 的提供是一项时间关键的干预措施,因为及时应用急性 NIV 可显著降低急性高碳酸血症性呼吸衰竭患者的死亡率。
本审计旨在评估延迟开始急性 NIV 的患者人数。我们还评估了开始急性 NIV 治疗的患者的入院结局。
收集了 2019 年 2 月 1 日至 3 月 31 日期间入住 Kings Mill 医院接受急性 NIV 的患者的数据。突出强调了对急性 NIV 的认识和知识作为一个有待改进的领域。设计并向医务人员发送了关于“急性 NIV”的电子学习包。对 2020 年 2 月 1 日至 3 月 31 日期间入住接受急性 NIV 的患者进行了重复审计,并使用卡方检验进行分析。
初始审计纳入了 25 例患者,重新审计纳入了 30 例患者。干预前,31%的患者延迟开始急性 NIV,干预后增加至 77%(p<0.0001)。干预前死亡率为 17%,干预后死亡率为 13%(p>0.05)。
需要进一步努力确保按照 BTS 标准持续提供急性 NIV,但在目标方面的不同成就似乎对患者结局没有显著的不利影响。